Size
Largest Healthcare companies by market cap
The most valuable US-listed companies, ranked by market capitalisation (share price times shares outstanding).
Top of the list: Eli Lilly and (LLY) $1.08T; Johnson & Johnson (JNJ) $632.9B; AbbVie (ABBV) $492.9B.
| # | Company | Market cap | Price | P/E | Revenue growth | Operating margin |
|---|---|---|---|---|---|---|
| 1 | Eli Lilly and CompanyLLY | $1.08T | $1,179.27 | 43.0x | +47.7% | — |
| 2 | Johnson & JohnsonJNJ | $632.9B | $261.44 | 30.5x | +6.6% | — |
| 3 | AbbVie IncABBV | $492.9B | $276.47 | 78.1x | +10.2% | 26.2% |
| 4 | Merck & Company IncMRK | $362.1B | $145.60 | 41.3x | +5.1% | — |
| 5 | UnitedHealth Group IncorporatedUNH | $334.2B | $379.30 | 27.7x | +0.4% | 4.8% |
| 6 | Novartis AG ADRNVS | $275.6B | $143.75 | 20.1x | — | — |
| 7 | Thermo Fisher Scientific IncTMO | $245.5B | $658.02 | 36.3x | +10.5% | 17.6% |
| 8 | AstraZeneca PLCAZN | $238.8B | $159.20 | 24.3x | +8.6% | 23.4% |
| 9 | Amgen IncAMGN | $217.3B | $414.87 | 28.0x | +9.5% | 30.0% |
| 10 | Gilead Sciences IncGILD | $184.1B | $151.17 | 20.2x | +10.2% | -8.2% |
| 11 | Abbott LaboratoriesABT | $174.8B | $99.60 | 28.1x | +7.8% | 17.1% |
| 12 | Novo Nordisk A/SNVO | $161.1B | $38.64 | 8.53x | +6.4% | 41.3% |
| 13 | Pfizer IncPFE | $159.3B | $28.28 | 21.3x | +2.6% | — |
| 14 | Intuitive Surgical IncISRG | $153.4B | $423.96 | 52.8x | +18.5% | 31.3% |
| 15 | Danaher CorporationDHR | $151.8B | $219.81 | 41.6x | +5.5% | 20.4% |
| 16 | Vertex Pharmaceuticals IncVRTX | $123.0B | $505.64 | 28.8x | +12.4% | 38.0% |
| 17 | Bristol-Myers Squibb CompanyBMY | $122.0B | $59.12 | 16.7x | +5.7% | 24.2% |
| 18 | Medtronic PLCMDT | $117.1B | $88.48 | 25.5x | +13.7% | 18.1% |
| 19 | McKesson CorporationMCK | $116.6B | $938.84 | 25.3x | +7.7% | 1.6% |
| 20 | Stryker CorporationSYK | $111.8B | $277.33 | 28.7x | +9.4% | 21.4% |
| 21 | CVS Health CorpCVS | $109.7B | $87.95 | 37.7x | +7.3% | 2.0% |
| 22 | Sanofi ADRSNY | $98.6B | $40.07 | 17.9x | — | — |
| 23 | HCA Holdings IncHCA | $94.7B | $451.09 | 14.7x | +4.3% | 12.8% |
| 24 | GlaxoSmithKline PLC ADRGSK | $93.4B | $46.50 | 12.3x | +4.1% | 24.3% |
| 25 | Elevance Health IncELV | $88.9B | $412.70 | 17.3x | +1.4% | 2.7% |
| 26 | Moderna IncMRNA | $81.0B | $225.00 | — | +2.1% | -149.0% |
| 27 | Cigna CorpCI | $70.9B | $282.43 | 11.1x | +6.7% | 3.5% |
| 28 | Regeneron Pharmaceuticals IncREGN | $68.5B | $746.54 | 16.0x | +16.7% | 24.7% |
| 29 | Cencora Inc.COR | $63.5B | $323.85 | 25.0x | +5.1% | 0.91% |
| 30 | Boston Scientific CorpBSX | $63.1B | $42.73 | 17.8x | +7.5% | 19.8% |
| 31 | Takeda Pharmaceutical Co Ltd ADRTAK | $59.3B | $18.73 | 49.4x | +7.5% | 7.5% |
| 32 | Cardinal Health IncCAH | $58.3B | $237.57 | 32.9x | +14.2% | 1.0% |
| 33 | Natera IncNTRA | $57.6B | $400.71 | — | +37.7% | -10.7% |
| 34 | Humana IncHUM | $52.8B | $431.87 | 46.9x | +25.7% | 39.6% |
| 35 | Veeva Systems Inc Class AVEEV | $50.7B | $296.13 | 57.1x | +17.6% | 29.9% |
| 36 | argenx NV ADRARGX | $50.6B | $825.03 | 42.2x | +88.6% | 24.8% |
| 37 | Becton Dickinson and CompanyBDX | $50.4B | $183.75 | 32.0x | +5.4% | 10.7% |
| 38 | Edwards Lifesciences CorpEW | $49.5B | $85.21 | 46.5x | +13.6% | 22.2% |
| 39 | Agilent Technologies IncA | $47.8B | $170.54 | 37.2x | +8.1% | 22.2% |
| 40 | Teva Pharma Industries Ltd ADRTEVA | $45.0B | $41.10 | 28.8x | -0.8% | 9.3% |
| 41 | Waters CorporationWAT | $42.6B | $435.99 | 108.7x | +113.3% | 7.1% |
| 42 | IQVIA Holdings IncIQV | $42.3B | $259.88 | 31.5x | +8.4% | 13.2% |
| 43 | IDEXX Laboratories IncIDXX | $42.2B | $518.00 | 39.3x | +9.7% | 32.0% |
| 44 | Haleon plcHLN | $42.1B | $9.32 | 19.4x | -1.8% | 21.9% |
| 45 | Illumina IncILMN | $41.1B | $278.17 | 49.4x | +9.4% | 19.6% |
| 46 | Revolution Medicines IncRVMD | $39.6B | $189.76 | — | -100.0% | — |
| 47 | DexCom IncDXCM | $39.6B | $84.11 | 41.2x | +13.1% | 22.9% |
| 48 | ResMed IncRMD | $34.4B | $230.05 | 22.8x | +8.6% | 33.4% |
| 49 | BeiGene, Ltd.ONC | $34.1B | $354.47 | 74.1x | +29.6% | 15.1% |
| 50 | Mettler-Toledo International IncMTD | $33.4B | $1,549.99 | 38.9x | +4.5% | — |
| 51 | Zoetis IncZTS | $33.3B | $74.81 | 13.0x | -0.2% | — |
| 52 | Royalty Pharma PlcRPRX | $32.3B | $56.93 | 29.5x | +16.5% | 59.6% |
| 53 | Alcon AGALC | $31.4B | $64.11 | 32.4x | +4.9% | 13.1% |
| 54 | GE HealthCare Technologies Inc.GEHC | $31.0B | $65.74 | 16.4x | +7.4% | 12.6% |
| 55 | Alnylam Pharmaceuticals IncALNY | $30.6B | $232.68 | 57.4x | +66.9% | — |
| 56 | Biogen IncBIIB | $30.4B | $218.43 | 22.2x | +1.9% | 16.3% |
| 57 | Medline Inc. Class A Common StockMDLN | $28.5B | $36.26 | — | +11.5% | 7.8% |
| 58 | Roivant Sciences LtdROIV | $27.2B | $35.44 | — | -33.5% | -7914.8% |
| 59 | West Pharmaceutical Services IncWST | $26.0B | $366.00 | 49.2x | +13.8% | 20.4% |
| 60 | Laboratory Corporation of America HoldingsLH | $25.9B | $312.15 | 28.0x | +5.8% | 10.4% |
| 61 | Quest Diagnostics IncorporatedDGX | $25.0B | $230.97 | 25.0x | +10.2% | 14.1% |
| 62 | BioNTech SEBNTX | $24.5B | $96.96 | — | +4.3% | -49.0% |
| 63 | Koninklijke Philips NV ADRPHG | $23.5B | $24.24 | 21.2x | -1.0% | 8.0% |
| 64 | United Therapeutics CorporationUTHR | $22.8B | $549.16 | 19.8x | -1.9% | 44.4% |
| 65 | Guardant Health IncGH | $22.1B | $167.47 | — | +44.3% | -39.8% |
| 66 | Genmab ASGMAB | $22.0B | $37.07 | 27.2x | +30.7% | 31.1% |
| 67 | Tenet Healthcare CorporationTHC | $21.9B | $259.83 | 13.2x | +6.8% | 20.8% |
| 68 | Incyte CorporationINCY | $21.8B | $112.79 | 15.4x | +20.9% | 30.1% |
| 69 | STERIS plcSTE | $21.4B | $214.40 | 27.5x | +7.3% | 18.9% |
| 70 | Insmed IncINSM | $19.6B | $100.60 | — | +296.1% | -73.9% |
| 71 | Viatris IncVTRS | $19.0B | $17.49 | — | +5.0% | -0.59% |
| 72 | Zimmer Biomet Holdings IncZBH | $17.9B | $89.14 | 24.0x | +4.8% | 14.2% |
| 73 | Medpace Holdings IncMEDP | $17.3B | $612.05 | 38.2x | +17.2% | 21.0% |
| 74 | Revvity Inc.RVTY | $17.3B | $154.18 | 74.5x | +1.3% | 12.3% |
| 75 | Solventum Corp.SOLV | $15.5B | $87.29 | 10.9x | +2.2% | 25.0% |
| 76 | Exelixis IncEXEL | $14.3B | $59.86 | 18.8x | +10.6% | 39.9% |
| 77 | Neurocrine Biosciences IncNBIX | $14.0B | $142.44 | 21.4x | +39.5% | 23.6% |
| 78 | Ascendis Pharma ASASND | $13.8B | $229.23 | 25.3x | +42.3% | -18.9% |
| 79 | Corcept Therapeutics IncorporatedCORT | $12.8B | $121.19 | 342.0x | +31.7% | 0.77% |
| 80 | Penumbra IncPEN | $12.7B | $319.40 | 74.5x | +14.9% | 12.4% |
| 81 | BrightSpring Health Services, Inc. Common StockBTSG | $12.7B | $63.74 | 84.8x | +23.1% | 3.1% |
| 82 | Halozyme Therapeutics IncHALO | $12.6B | $110.42 | 37.1x | +47.7% | 35.9% |
| 83 | ICON PLCICLR | $12.4B | $164.17 | 21.4x | +1.2% | 3.6% |
| 84 | BridgeBio Pharma IncBBIO | $12.3B | $65.35 | — | +120.4% | -69.8% |
| 85 | Summit Therapeutics PLCSMMT | $12.1B | $17.59 | — | — | — |
| 86 | Tempus AI, Inc. Class A Common StockTEM | $12.0B | $70.35 | — | +21.6% | -19.8% |
| 87 | Smith & Nephew SNATS IncSNN | $12.0B | $27.24 | 37.8x | +6.1% | 12.9% |
| 88 | Encompass Health CorpEHC | $11.9B | $123.33 | 20.6x | +9.6% | 18.0% |
| 89 | 10X Genomics IncTXG | $11.7B | $80.65 | — | -12.7% | -14.3% |
| 90 | Fresenius Medical Care CorporationFMS | $11.5B | $21.06 | 11.2x | -0.3% | 9.3% |
| 91 | DaVita HealthCare Partners IncDVA | $11.5B | $179.25 | 17.3x | +5.2% | 15.2% |
| 92 | Bio-Techne CorpTECH | $11.5B | $72.46 | 104.9x | +1.3% | 20.7% |
| 93 | Dr. Reddy’s Laboratories Ltd ADRRDY | $10.9B | $12.48 | 25.2x | +16.6% | 22.1% |
| 94 | Madrigal Pharmaceuticals IncMDGL | $10.7B | $471.75 | — | +71.2% | -25.1% |
| 95 | Globus MedicalGMED | $10.7B | $74.65 | 18.4x | +5.9% | 20.3% |
| 96 | The Cooper Companies, IncCOO | $10.6B | $54.37 | 27.1x | +0.6% | 12.8% |
| 97 | Immunitybio IncIBRX | $10.5B | $10.51 | — | +93.9% | -151.9% |
| 98 | Universal Health Services IncUHS | $10.4B | $177.35 | 7.21x | +8.3% | 11.4% |
| 99 | Oscar Health IncOSCR | $10.4B | $33.37 | — | -6.2% | 2128.9% |
| 100 | Elanco Animal HealthELAN | $10.4B | $22.92 | — | +10.2% | — |
Ranked from each company's latest price and reported results. Companies need a page on Investingly (SEC statements on file). Open any company for its reverse DCF, insider buying and 13F holders.
Other sectors
Largest US companies by market cap (all sectors)Largest Technology companies by market capLargest Financial Services companies by market capLargest Communication Services companies by market capLargest Consumer Cyclical companies by market capLargest Industrials companies by market capLargest Energy companies by market capLargest Consumer Defensive companies by market capLargest Basic Materials companies by market capLargest Utilities companies by market capLargest Real Estate companies by market cap
More size lists
Questions
Which company ranks first on the largest healthcare companies by market cap list?
Eli Lilly and (LLY), with a market cap of $1.08T, as of October 12, 2026.
How is this list built?
The most valuable US-listed companies, ranked by market capitalisation (share price times shares outstanding). It shows the top 100 and is rebuilt every day.
Prices and ratios as of Oct 11, 2026. Statements from SEC filings. Information only, not investment advice.